D. Mugo

发表

Seroprevalence of Antibodies to Severe Acute Respiratory Syndrome Coronavirus 2 Among Healthcare Workers in Kenya

J. Scott, C. Agoti, D. Nokes, 2021, Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America.

Sero-surveillance for IgG to SARS-CoV-2 at antenatal care clinics in three Kenyan referral hospitals: repeated cross-sectional surveys 2020-21

J. Scott, C. Agoti, I. Adetifa, 2022, medRxiv.

Performance of the MGIT TBc Identification Test and Meta-Analysis of MPT64 Assays for Identification of the Mycobacterium tuberculosis Complex in Liquid Culture

A. Brent, J. Scott, M. Levin, 2011, Journal of Clinical Microbiology.

The Prevalence and Risk Factors for Pneumococcal Colonization of the Nasopharynx among Children in Kilifi District, Kenya

M. Lipsitch, J. Scott, D. Mugo, 2012, PloS one.

Standardization of Laboratory Methods for the PERCH Study

S. Madhi, K. O'Brien, R. Karron, 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

SARS-CoV-2 seroprevalence in three Kenyan health and demographic surveillance sites, December 2020-May 2021

J. Scott, C. Agoti, P. Bejon, 2022, medRxiv.

Seroprevalence of Antibodies to Severe Acute Respiratory Syndrome Coronavirus 2 Among Healthcare Workers in Kenya

J. Scott, C. Agoti, D. Nokes, 2021, medRxiv.

Comparative performance of WANTAI ELISA for total immunoglobulin to receptor binding protein and an ELISA for IgG to spike protein in detecting SARS-CoV-2 antibodies in Kenyan populations

J. Scott, P. Bejon, I. Adetifa, 2021, Journal of Clinical Virology.

Anti-Severe Acute Respiratory Syndrome Coronavirus 2 Immunoglobulin G Antibody Seroprevalence Among Truck Drivers and Assistants in Kenya

J. Scott, C. Agoti, P. Bejon, 2021, Open forum infectious diseases.

Kinetics of naturally induced binding and neutralizing anti-SARS-CoV-2 antibody levels and potencies among Kenyan patients with diverse grades of COVID-19 severity

E. Nduati, G. Warimwe, A. Abdi, 2022, medRxiv.

Serum immunoglobulin G and mucosal immunoglobulin A antibodies from prepandemic samples collected in Kilifi, Kenya, neutralize SARS-CoV-2 in vitro

E. Nduati, J. Scott, C. Agoti, 2022, International Journal of Infectious Diseases.

COVID-19 transmission dynamics underlying epidemic waves in Kenya

M. Keeling, E. Okiro, J. Scott, 2021, Science.

Seroprevalence of anti–SARS-CoV-2 IgG antibodies in Kenyan blood donors

J. Scott, C. Agoti, P. Bejon, 2020, Science.

Quantifying previous SARS-CoV-2 infection through mixture modelling of antibody levels

J. Scott, I. Adetifa, C. Bottomley, 2021, Nature Communications.

Temporal trends of SARS-CoV-2 seroprevalence during the first wave of the COVID-19 epidemic in Kenya

J. Scott, P. Bejon, I. Adetifa, 2021, Nature Communications.

Improving SARS-CoV-2 cumulative incidence estimation through mixture modelling of antibody levels

J. Scott, I. Adetifa, C. Bottomley, 2021, medRxiv.

Temporal trends of SARS-CoV-2 seroprevalence in transfusion blood donors during the first wave of the COVID-19 epidemic in Kenya

J. Scott, P. Bejon, I. Adetifa, 2021, medRxiv.

Anti-Severe Acute Respiratory Syndrome Coronavirus 2 Immunoglobulin G Antibody Seroprevalence Among Truck Drivers and Assistants in Kenya

J. Scott, C. Agoti, P. Bejon, 2021, Open forum infectious diseases.

Seroprevalence of anti-SARS-CoV-2 IgG antibodies among truck drivers and assistants in Kenya

J. Scott, C. Agoti, P. Bejon, 2021, medRxiv.

Pooled testing conserves SARS-CoV-2 laboratory resources and improves test turn-around time: experience on the Kenyan Coast.

Khadija Said Mohammed, C. Agoti, P. Bejon, 2020, Wellcome open research.

Pooled testing conserves SARS-CoV-2 laboratory resources and improves test turn-around time: experience on the Kenyan Coast

Khadija Said Mohammed, C. Agoti, P. Bejon, 2021, Wellcome open research.

Rates of Acquisition of Pneumococcal Colonization and Transmission Probabilities, by Serotype, Among Newborn Infants in Kilifi District, Kenya

J. Scott, H. Gatakaa, D. Mugo, 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Rates of Acquisition and Clearance of Pneumococcal Serotypes in the Nasopharynges of Children in Kilifi District, Kenya

Marc Lipsitch, Robert Musyimi, M. Lipsitch, 2012, The Journal of infectious diseases.

Maintaining laboratory quality assurance and safety in a pandemic: Experiences from the KEMRI-Wellcome Trust Research Programme laboratory’s COVID-19 response

Khadija Said Mohammed, C. Agoti, P. Bejon, 2021, Wellcome Open Research.

Sero-surveillance for IgG to SARS-CoV-2 at antenatal care clinics in two Kenyan referral hospitals

J. Scott, C. Agoti, P. Bejon, 2021, medRxiv.

Bacteriological diagnosis of childhood TB: a prospective observational study

A. Brent, J. Scott, M. Levin, 2017, Scientific Reports.

Immunogenicity and safety of fractional doses of 17D-213 yellow fever vaccine in HIV-infected people in Kenya (YEFE): a randomised, double-blind, non-inferiority substudy of a phase 4 trial

O. Faye, K. Grantz, P. Bejon, 2023, The Lancet. Infectious diseases.

An optimization of four SARS-CoV-2 qRT-PCR assays in a Kenyan laboratory to support the national COVID-19 rapid response teams

C. Agoti, P. Bejon, J. Musyoki, 2022, Wellcome open research.

An optimisation of four SARS-CoV-2 qRT-PCR assays in a Kenyan laboratory to support the national COVID-19 rapid response teams.

C. Agoti, P. Bejon, J. Musyoki, 2020, Wellcome open research.

Validation of saline, PBS and a locally produced VTM at varying storage conditions to detect the SARS-CoV-2 virus by qRT-PCR

P. Bejon, C. Ngetsa, B. Orindi, 2022, bioRxiv.

Safety and immunogenicity of ChAdOx1 nCoV-19 (AZD1222) vaccine in adults in Kenya: a phase 1/2 single-blind, randomised controlled trial

E. Nduati, C. Agoti, P. Bejon, 2023, Wellcome Open Research.

Epidemiology of COVID-19 infections on routine polymerase chain reaction (PCR) and serology testing in Coastal Kenya

C. Agoti, D. Nokes, G. Githinji, 2022, Wellcome open research.

Kinetics of naturally induced binding and neutralising anti-SARS-CoV-2 antibody levels and potencies among SARS-CoV-2 infected Kenyans with diverse grades of COVID-19 severity: an observational study

E. Nduati, P. Bejon, S. Sayed, 2023, Wellcome Open Research.

The genomic epidemiology of SARS-CoV-2 variants of concern in Kenya

A. Rambaut, M. Cotten, C. Agoti, 2022, medRxiv.

SARS-CoV-2 seroprevalence and implications for population immunity: Evidence from two Health and Demographic Surveillance System sites in Kenya, February-June 2022

J. Scott, M. Kimani, I. Adetifa, 2022, medRxiv.

SARS‐CoV‐2 seroprevalence and implications for population immunity: Evidence from two Health and Demographic Surveillance System sites in Kenya, February–December 2022

M. Kimani, P. Bejon, I. Adetifa, 2023, Influenza and other respiratory viruses.

Temporal trends of dengue seroprevalence among children in coastal Kenya, 1998-2018: a longitudinal cohort study

G. Warimwe, J. Musyoki, P. Bejon, 2023, medRxiv.